Gabriel Capella

Gabriel Capella

UNVERIFIED PROFILE

Are you Gabriel Capella?   Register this Author

Register author
Gabriel Capella

Gabriel Capella

Publications by authors named "Gabriel Capella"

Are you Gabriel Capella?   Register this Author

100Publications

3964Reads

36Profile Views

Contribution to colonic polyposis of recently proposed predisposing genes and assessment of the prevalence of NTHL1- and MSH3-associated polyposes.

Hum Mutat 2019 Nov 29;40(11):1910-1923. Epub 2019 Jul 29.

Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/humu.23853DOI Listing
November 2019

Approaches to functionally validate candidate genetic variants involved in colorectal cancer predisposition.

Mol Aspects Med 2019 Oct 1;69:27-40. Epub 2019 Apr 1.

Gastroenterology Department, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), University of Barcelona, Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mam.2019.03.004DOI Listing
October 2019

Expression and Role of MicroRNAs from the miR-200 Family in the Tumor Formation and Metastatic Propensity of Pancreatic Cancer.

Mol Ther Nucleic Acids 2019 Sep 29;17:491-503. Epub 2019 Jun 29.

Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; CIBERONC, Centro de Investigación Biomédica en Red en Cáncer, Madrid, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.omtn.2019.06.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656921PMC
September 2019

Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database.

Genet Med 2019 Jul 24. Epub 2019 Jul 24.

Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41436-019-0596-9DOI Listing
July 2019

Germline variation in O-methylguanine-DNA methyltransferase (MGMT) as cause of hereditary colorectal cancer.

Cancer Lett 2019 Apr 21;447:86-92. Epub 2019 Jan 21.

Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain; Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2019.01.019DOI Listing
April 2019

Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report.

Hered Cancer Clin Pract 2019 28;17. Epub 2019 Feb 28.

4Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, part of Oslo University Hospital, Olso, Norway.

View Article

Download full-text PDF

Source
https://hccpjournal.biomedcentral.com/articles/10.1186/s1305
Publisher Site
http://dx.doi.org/10.1186/s13053-019-0106-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394091PMC
February 2019

Evidence suggests that germline mutations are a rare cause of serrated polyposis.

Gut 2018 12 12;67(12):2230-2232. Epub 2018 Jan 12.

Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://gut.bmj.com/lookup/doi/10.1136/gutjnl-2017-315733
Publisher Site
http://dx.doi.org/10.1136/gutjnl-2017-315733DOI Listing
December 2018

New Methylation Biomarker Panel for Early Diagnosis of Dysplasia or Cancer in High-Risk Inflammatory Bowel Disease Patients.

Inflamm Bowel Dis 2018 11;24(12):2555-2564

Department of General and Digestive Surgery, Colorectal Unit, University Hospital Bellvitge (HUB-IDIBELL)-CIBERONC, L'Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ibd/izy255DOI Listing
November 2018

Cancer Risks for PMS2-Associated Lynch Syndrome.

J Clin Oncol 2018 10 30;36(29):2961-2968. Epub 2018 Aug 30.

Sanne W. ten Broeke, Heleen M. van der Klift, Carli M.J. Tops, Manon Suerink, Frederik J. Hes, Hans F.A. Vasen, Juul T. Wijnen, and Maartje Nielsen, Leiden University Medical Center, Leiden; Encarna Gomez Garcia, Maastricht University Medical Center, Maastricht; Nicoline Hoogerbrugge, Arjen R. Mensenkamp, and Liesbeth Spruijt, Radboud University Medical Center, Nijmegen; Tom G.W. Letteboer, University Medical Center, Utrecht; Theo A.M. van Os and Egbert J.W. Redeker, Academic Medical Center, Amsterdam; Maran J.W. Olderode-Berends and Yvonne J. Vos, University of Groningen; University Medical Center Groningen, Groningen; Anja Wagner, Erasmus Medical Center, Rotterdam, the Netherlands; Stefan Aretz, University of Bonn; University Hospital Bonn, Bonn; Christoph Engel, Leipzig University; Medizinisch Genetisches Zentrum Bayerstr, Leipzig; Magnus von Knebel Doeberitz, University of Heidelberg; German Cancer Research Center, Heidelberg; Pål Møller, University of Witten-Herdecke, Wuppertal; Nils Rahner, Heinrich-Heine-University, Düsseldorf; Hans K. Schackert, Technische Universität Dresden, Dresden; Verena Steinke-Lange, Medizinische Klinik und Poliklinik IV Campus Innenstadt, Klinikum der Universität München, Munich, Germany; Pål Møller, The Norwegian Radium Hospital; Oslo University Hospital, Oslo, Norway; Inge Bernstein, Hvidovre Hospital, Hvidovre, and Aalborg University Hospital, Aalborg, Denmark; Daniel D. Buchanan, Mark Clendenning, John L. Hopper, Mark A. Jenkins, Christophe Rosty, Ingrid Winship, and Aung Ko Win, The University of Melbourne; Daniel D. Buchanan, Ingrid Winship, and Aung Ko Win, Royal Melbourne Hospital, Parkville, Melbourne, Victoria; Rodney Scott, University of Newcastle, Newcastle, New South Wales, Australia; Albert de la Chapelle, Heather L. Hampel, Rachel Pearlman, and Leigha Senter, The Ohio State University Comprehensive Cancer Center, Columbus, OH; Gabriel Capella and Marta Pineda, Institut d'Investigació Biomédica de Bellvitge, Barcelona, Spain; Steven Gallinger, Mount Sinai Hospital, Toronto, Ontario, Canada; Jane C. Figueiredo and Robert Haile, Cedars-Sinai Medical Center, Los Angeles, CA; Loic Le Marchand, University of Hawaii Cancer Center, Honolulu, HI; Annika Lindblom, Karolinska Institutet; Karolinska University Hospital, Stockholm, Sweden; Noralane M. Lindor, Mayo Clinic Arizona, Scottsdale, AZ; Polly A. Newcomb, Fred Hutchinson Cancer Research Center; University of Washington, Seattle, WA; and Stephen Thibodeau, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2018.78.4777
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.78.4777DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349460PMC
October 2018

Primary constitutional MLH1 epimutations: a focal epigenetic event.

Br J Cancer 2018 10 4;119(8):978-987. Epub 2018 Oct 4.

Hereditary Cancer Program, Catalan Institute of Oncology-Bellvitge Biomedical Research Institute (ICO-IDIBELL),ONCOBELL, CIBERONC, Av.Gran Via de l'Hospitalet 199-203, L'Hospitalet de Llobregat, 08908, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-018-0019-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203851PMC
October 2018

Comprehensive analysis of copy number aberrations in microsatellite stable colon cancer in view of stromal component.

Br J Cancer 2017 Jul 6;117(3):421-431. Epub 2017 Jul 6.

Unit of Biomarkers and Susceptibility, Cancer Prevention and Control Program, Catalan Institute of Oncology (ICO), CIBERESP, Gran Via 199, Hospitalet Llobregat, 08908 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2017.208DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537504PMC
July 2017

Delineating the Phenotypic Spectrum of the NTHL1-Associated Polyposis.

Clin Gastroenterol Hepatol 2017 03 5;15(3):461-462. Epub 2016 Oct 5.

Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2016.09.153DOI Listing
March 2017

Genomic Landscape of Colorectal Mucosa and Adenomas.

Cancer Prev Res (Phila) 2016 06 24;9(6):417-27. Epub 2016 May 24.

Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas. Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas. Clinical Cancer Genetics Program, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-16-0081DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941624PMC
June 2016

Nanofluidic Digital PCR and Extended Genotyping of RAS and BRAF for Improved Selection of Metastatic Colorectal Cancer Patients for Anti-EGFR Therapies.

Mol Cancer Ther 2016 05 1;15(5):1106-12. Epub 2016 Apr 1.

Translational Research Laboratory, Catalan Insitute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. Department of Medical Oncology, Catalan Insitute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-15-0820DOI Listing
May 2016

Investigating the effect of 28 BRCA1 and BRCA2 mutations on their related transcribed mRNA.

Breast Cancer Res Treat 2016 Jan 16;155(2):253-60. Epub 2016 Jan 16.

Hereditary Cancer Program, Molecular Diagnostics Unit, Catalan Institute of Oncology (ICO-IDIBELL), Hospital Duran i Reynals, Gran Via 199, L'Hospitalet de Llobregat, 08908, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-015-3676-9DOI Listing
January 2016

AMER1 Is a Frequently Mutated Gene in Colorectal Cancer--Letter.

Clin Cancer Res 2015 Nov;21(21):4985

Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-1756DOI Listing
November 2015

Tumor growth delay by adjuvant alternating electric fields which appears non-thermally mediated.

Bioelectrochemistry 2015 Oct 16;105:16-24. Epub 2015 Apr 16.

Universitat Pompeu Fabra, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bioelechem.2015.04.006DOI Listing
October 2015

Genomic classifier ColoPrint predicts recurrence in stage II colorectal cancer patients more accurately than clinical factors.

Oncologist 2015 Feb 5;20(2):127-33. Epub 2015 Jan 5.

Departments of Gastrointestinal Medical Oncology and Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain; Department of Surgery, Klinikum Rechts der Isar, Technische University, Munich, Germany; Institut Català d'Oncologia, IDIBELL L'Hospitalet de Llobregat, Barcelona, Spain; Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain; Department of Surgery, Medical University of Vienna, Vienna, Austria; Department of Surgery, University of Ferrara, Ferrara, Italy; Agendia NV, Amsterdam, The Netherlands; Agendia Inc., Irvine, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0325DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319631PMC
February 2015

Paracrine network: another step in the complexity of resistance to EGFR blockade?

Clin Cancer Res 2014 Dec 19;20(24):6227-9. Epub 2014 Aug 19.

Medical Oncology Department, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-1615DOI Listing
December 2014

Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.

Gastroenterology 2014 Oct 3;147(4):882-892.e8. Epub 2014 Jul 3.

Departament de Biologia Cellular, Immunologia i Neurociències, Facultat de Medicina, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2014.06.041DOI Listing
October 2014

KRAS-G12C mutation is associated with poor outcome in surgically resected lung adenocarcinoma.

J Thorac Oncol 2014 Oct;9(10):1513-22

*Thoracic Surgery, Department of Surgery, University of Michigan Medical School, Ann Arbor, Michigan; †Michigan Center for Translational Pathology, Department of Pathology, University of Michigan, Ann Arbor, Michigan; ‡Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan; §Department of Biostatistics, University of Michigan, Ann Arbor, Michigan; ‖Veterans Administration Medical Center, Ann Arbor, Michigan; ¶Translational Research Laboratory, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona, Spain; and #Department of Medical Oncology, Thoracic Oncology Multidisciplinary Unit, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000305DOI Listing
October 2014

Relationship between methylation and colonic inflammation in inflammatory bowel disease.

World J Gastroenterol 2014 Aug;20(30):10591-8

Triana Lobatón, Francisco Rodríguez-Moranta, Jordi Guardiola, Department of Gastroenterology, University Hospital of Bellvitge, IDIBELL, Hospitalet de Llobregat, 08907 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v20.i30.10591DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130871PMC
August 2014

Comprehensive molecular characterisation of hereditary non-polyposis colorectal tumours with mismatch repair proficiency.

Eur J Cancer 2014 Jul 16;50(11):1964-72. Epub 2014 May 16.

Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2014.04.022DOI Listing
July 2014

Phosphorylation at Ser-181 of oncogenic KRAS is required for tumor growth.

Cancer Res 2014 Feb 26;74(4):1190-9. Epub 2013 Dec 26.

Authors' Affiliations: Departament de Biologia Cel·lular, Immunologia i Neurociències, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Facultat de Medicina, Universitat de Barcelona; Hereditary Cancer Program, Translational Research Laboratory, Catalan Institute of Oncology, ICO-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain; Gran Via 199-203, 08907- L'Hospitalet de Llobregat, Llobregat; Servei d'Anatomia Patològica i Institut de Recerca Biomèdica de Lleida, Lleida, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-13-1750DOI Listing
February 2014

GALNT12 is not a major contributor of familial colorectal cancer type X.

Hum Mutat 2014 Jan 17;35(1):50-2. Epub 2013 Oct 17.

Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/humu.22454DOI Listing
January 2014

An association between the PTGS2 rs5275 polymorphism and colorectal cancer risk in families with inherited non-syndromic predisposition.

Eur J Hum Genet 2013 Dec 27;21(12):1389-95. Epub 2013 Mar 27.

1] CSIRO, Preventative Health National Research Flagship, North Ryde, NSW, Australia [2] Animal, Food and Health Sciences, CSIRO, North Ryde, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ejhg.2013.53DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3831072PMC
December 2013

Epigenetic inactivation of microRNA-34b/c predicts poor disease-free survival in early-stage lung adenocarcinoma.

Clin Cancer Res 2013 Dec 15;19(24):6842-52. Epub 2013 Oct 15.

Authors' Affiliations: Thoracic Surgery, Department of Surgery, University of Michigan Medical School, Ann Arbor, Michigan; and Translational Research Laboratory and Departments of Pathology, Thoracic Surgery, and Medical Oncology, Thoracic Oncology Multidisciplinary Unit, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/19/24/6842.ful
Web Search
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-13-0736DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161219PMC
December 2013

Functional and structural analysis of C-terminal BRCA1 missense variants.

PLoS One 2013 17;8(4):e61302. Epub 2013 Apr 17.

Hereditary Cancer Program, Catalan Institute of Oncology-Bellvitge Institute for Biomedical Research, Girona Institute for Biomedical Research, Germans Trial i Pujol Research Institute, ICO-IDIBELL, ICO-IdIBGi, ICO-IGTP, L'Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0061302PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629201PMC
November 2013

Telomere length and genetic anticipation in Lynch syndrome.

PLoS One 2013 23;8(4):e61286. Epub 2013 Apr 23.

Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0061286PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634050PMC
November 2013

Metronomic chemotherapy following the maximum tolerated dose is an effective anti-tumour therapy affecting angiogenesis, tumour dissemination and cancer stem cells.

Int J Cancer 2013 Nov 4;133(10):2464-72. Epub 2013 Jun 4.

Translational Research Laboratory, Catalan Institute of Oncology, IDIBELL, Hospital Duran i Reynals, L'Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.28259DOI Listing
November 2013

Grape antioxidant dietary fiber inhibits intestinal polyposis in ApcMin/+ mice: relation to cell cycle and immune response.

Carcinogenesis 2013 Aug 24;34(8):1881-8. Epub 2013 Apr 24.

Department of Biochemistry and Molecular Biology, IBUB, Faculty of Biology, Universitat de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgt140DOI Listing
August 2013

[Hyperplastic polyposis syndrome: phenotypic diversity and association to colorectal cancer].

Med Clin (Barc) 2013 Jul 17;141(2):62-6. Epub 2012 Jul 17.

Programa de Cáncer Hereditario, Unidad de Consejo Genético, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2012.04.024DOI Listing
July 2013

DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer.

Cancer Prev Res (Phila) 2013 Jul 21;6(7):656-65. Epub 2013 May 21.

Cancer Epigenetics and Biology Program (PEBC), Catalan Institute of Oncology (ICO-IDIBELL), Barcelona 08908, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-12-0501DOI Listing
July 2013

Clinical value of prognosis gene expression signatures in colorectal cancer: a systematic review.

PLoS One 2012 7;7(11):e48877. Epub 2012 Nov 7.

Unit of Biomarkers and Susceptibility (UBS), Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), and CIBERESP, L'Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0048877PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492249PMC
May 2013

Usefulness of epithelial cell adhesion molecule expression in the algorithmic approach to Lynch syndrome identification.

Hum Pathol 2013 Mar 29;44(3):412-6. Epub 2012 Sep 29.

Department of Pathology, Hospital Universitari Germans Trias i Pujol, C/ Ctra de Canyet s/n, 08916 Badalona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2012.06.006DOI Listing
March 2013

Genetic and epigenetic markers in the evaluation of pancreatic masses.

J Clin Pathol 2013 Mar 7;66(3):192-7. Epub 2012 Nov 7.

Translational Research Laboratory, Hereditary Cancer Program, Institut Català d´Oncologia-IDIBELL, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jclinpath-2012-201123DOI Listing
March 2013

The impact of KRAS mutations on VEGF-A production and tumour vascular network.

BMC Cancer 2013 Mar 18;13:125. Epub 2013 Mar 18.

Translational Research Laboratory, Institut Català d'Oncologia-IDIBELL, Gran Via 199-203, 08908 L'Hospitalet del Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-13-125DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610256PMC
March 2013

MLH1 methylation screening is effective in identifying epimutation carriers.

Eur J Hum Genet 2012 Dec 4;20(12):1256-64. Epub 2012 Jul 4.

Hereditary Cancer Program, Catalan Institute of Oncology, ICO-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ejhg.2012.136DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499751PMC
December 2012

Comprehensive functional assessment of MLH1 variants of unknown significance.

Hum Mutat 2012 Nov 12;33(11):1576-88. Epub 2012 Jul 12.

Hereditary Cancer Program, Catalan Institute of Oncology, ICO-IDIBELL, Hospitalet de Llobregat, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/humu.22142DOI Listing
November 2012

Stromal interaction molecule 2 (STIM2) is frequently overexpressed in colorectal tumors and confers a tumor cell growth suppressor phenotype.

Mol Carcinog 2012 Sep 30;51(9):746-53. Epub 2011 Aug 30.

Translational Research Laboratory, Institut Català d'Oncologia-Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mc.20843DOI Listing
September 2012

Nanofluidic digital PCR for KRAS mutation detection and quantification in gastrointestinal cancer.

Clin Chem 2012 Sep 27;58(9):1332-41. Epub 2012 Jun 27.

Translational Research Laboratory, Catalan Institute of Oncology-ICO-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2012.186577DOI Listing
September 2012

An optimized predictor panel for colorectal cancer diagnosis based on the combination of tumor-associated antigens obtained from protein and phage microarrays.

J Proteomics 2012 Aug 18;75(15):4647-55. Epub 2012 Mar 18.

Functional Proteomics Laboratory, Centro de Investigaciones Biológicas (CIB-CSIC), 28040 Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jprot.2012.03.004DOI Listing
August 2012

Genetic variation in MUC1, MUC2 and MUC6 genes and evolution of gastric cancer precursor lesions in a long-term follow-up in a high-risk area in Spain.

Carcinogenesis 2012 May 7;33(5):1072-80. Epub 2012 Mar 7.

Translational Research Laboratory, Institut Català d'Oncologia (IDIBELL-ICO), Gran Via, km 2.7 s/n, 08907 L'Hospitalet de Llobregat, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgs119DOI Listing
May 2012

Analysis of SLX4/FANCP in non-BRCA1/2-mutated breast cancer families.

BMC Cancer 2012 Mar 8;12:84. Epub 2012 Mar 8.

Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Hospital Duran i Reynals, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-12-84DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315397PMC
March 2012

Identification of a new complex rearrangement affecting exon 20 of BRCA1.

Breast Cancer Res Treat 2011 Nov 15;130(1):341-4. Epub 2011 Jul 15.

Hereditary Cancer Program, Institut Català d'Oncologia, Hospital Duran i Reynals - Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona and Hospital Josep Trueta, IDIBGI, Girona (JB, ED, AI and AV), Spain.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-011-1673-1
Publisher Site
http://dx.doi.org/10.1007/s10549-011-1673-1DOI Listing
November 2011

Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.

Authors:
Christopher A Maxwell Javier Benítez Laia Gómez-Baldó Ana Osorio Núria Bonifaci Ricardo Fernández-Ramires Sylvain V Costes Elisabet Guinó Helen Chen Gareth J R Evans Pooja Mohan Isabel Català Anna Petit Helena Aguilar Alberto Villanueva Alvaro Aytes Jordi Serra-Musach Gad Rennert Flavio Lejbkowicz Paolo Peterlongo Siranoush Manoukian Bernard Peissel Carla B Ripamonti Bernardo Bonanni Alessandra Viel Anna Allavena Loris Bernard Paolo Radice Eitan Friedman Bella Kaufman Yael Laitman Maya Dubrovsky Roni Milgrom Anna Jakubowska Cezary Cybulski Bohdan Gorski Katarzyna Jaworska Katarzyna Durda Grzegorz Sukiennicki Jan Lubiński Yin Yao Shugart Susan M Domchek Richard Letrero Barbara L Weber Frans B L Hogervorst Matti A Rookus J Margriet Collee Peter Devilee Marjolijn J Ligtenberg Rob B van der Luijt Cora M Aalfs Quinten Waisfisz Juul Wijnen Cornelis E P van Roozendaal Douglas F Easton Susan Peock Margaret Cook Clare Oliver Debra Frost Patricia Harrington D Gareth Evans Fiona Lalloo Rosalind Eeles Louise Izatt Carol Chu Diana Eccles Fiona Douglas Carole Brewer Heli Nevanlinna Tuomas Heikkinen Fergus J Couch Noralane M Lindor Xianshu Wang Andrew K Godwin Maria A Caligo Grazia Lombardi Niklas Loman Per Karlsson Hans Ehrencrona Anna von Wachenfeldt Rosa Bjork Barkardottir Ute Hamann Muhammad U Rashid Adriana Lasa Trinidad Caldés Raquel Andrés Michael Schmitt Volker Assmann Kristen Stevens Kenneth Offit João Curado Hagen Tilgner Roderic Guigó Gemma Aiza Joan Brunet Joan Castellsagué Griselda Martrat Ander Urruticoechea Ignacio Blanco Laima Tihomirova David E Goldgar Saundra Buys Esther M John Alexander Miron Melissa Southey Mary B Daly Rita K Schmutzler Barbara Wappenschmidt Alfons Meindl Norbert Arnold Helmut Deissler Raymonda Varon-Mateeva Christian Sutter Dieter Niederacher Evgeny Imyamitov Olga M Sinilnikova Dominique Stoppa-Lyonne Sylvie Mazoyer Carole Verny-Pierre Laurent Castera Antoine de Pauw Yves-Jean Bignon Nancy Uhrhammer Jean-Philippe Peyrat Philippe Vennin Sandra Fert Ferrer Marie-Agnès Collonge-Rame Isabelle Mortemousque Amanda B Spurdle Jonathan Beesley Xiaoqing Chen Sue Healey Mary Helen Barcellos-Hoff Marc Vidal Stephen B Gruber Conxi Lázaro Gabriel Capellá Lesley McGuffog Katherine L Nathanson Antonis C Antoniou Georgia Chenevix-Trench Markus C Fleisch Víctor Moreno Miguel Angel Pujana

PLoS Biol 2011 Nov 15;9(11):e1001199. Epub 2011 Nov 15.

Translational Research Laboratory, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute-IDIBELL, L'Hospitalet, Catalonia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pbio.1001199DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3217025PMC
November 2011